Atika Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-70,000
| Closed | -$4.91M | – | 86 |
|
|
2024
Q1 | $4.91M | Buy |
70,000
+19,000
| +37% | +$1.33M | 0.48% | 65 |
|
|
2023
Q4 | $4.26M | Buy |
+51,000
| New | +$4.26M | 0.57% | 58 |
|
|
2023
Q2 | – | Sell |
-75,063
| Closed | -$2.64M | – | 78 |
|
|
2023
Q1 | $2.64M | Buy |
75,063
+9,063
| +14% | +$319K | 0.39% | 59 |
|
|
2022
Q4 | $3.02M | Sell |
66,000
-94,310
| -59% | -$4.32M | 0.43% | 48 |
|
|
2022
Q3 | $7.77M | Buy |
160,310
+33,300
| +26% | +$1.61M | 0.66% | 45 |
|
|
2022
Q2 | $4.99M | Buy |
+127,010
| New | +$4.99M | 0.56% | 44 |
|